Gentium S.p.A. (GENT) - Financial and Strategic SWOT Analysis Review

Document Sample
Gentium S.p.A. (GENT) - Financial and Strategic SWOT Analysis Review Powered By Docstoc
					        Gentium S.p.A. (GENT) - Financial and Strategic SWOT Analysis Review
        Reference Code: GDPH56864FSA                                                                                           Publication Date: JUN 2013

          Piazza XX Settembre, 2                             Phone              +39 031 385217                  Revenue          23.88 (million EUR)
          Villa Guardia, Como                                Fax                +39 031 385241                  Net Profit       0.77 (million EUR)
          22079                                              Website            www.gentium.it                  Employees        77
                                                                                                                                 Pharmaceuticals           &
          Italy                                              Exchange           GENT [NASDAQ]                   Industry
                                                                                                                                 Healthcare

       Company Overview
       Gentium S.p.A. (Gentium) is a biopharmaceutical company. It researches, develops and manufactures potential therapeutic
       agents. The company develops drugs to treat and prevent various vascular diseases and conditions related to cancer treatments.
       Gentium completed two clinical trials of its product defibrotide, which include a Phase III trial for the treatment of severe Veno
       Occlusive Disease (VOD) in the US, Canada and Israel; and a Phase II/III pediatric trial in Europe for the prevention of VOD. In
       addition, two groups of compounds, namely, Oligotide and Nmers are currently being investigated in pre-clinical stage of
       development.
       Key Executives                                                                SWOT Analysis
                      Name                                 Title                      Gentium S.p.A., SWOT Analysis
         Dr. Khalid Islam                    Chairman                                 Strengths                              Weaknesses
         Gigliola Bertoglio                  Director
                                                                                      Sturdy Research and                    Business Concentration: the UK
         Dr. Glenn Cooper                    Director                                 Development Activities
                                                                                                                             Reliance on the Third Parties
         Dr. Laura Ferro                     Director
                                                                                      Intellectual Property
         Dr. Bobby W. Sandage                Director
        Source: Annual Report, Company Website, Primary and Secondary
        Research, GlobalData                                                          Opportunities                          Threats

       Share Data                                                                     Orphan Drug Designation                Competitive Pressures
         Gentium S.p.A.
                                                                                      Licensing and Distribution             Government Regulations
        Share Price (EUR) as on 04-Jun-                                  8.36         Agreements
        2013
        EPS (EUR)                                                        0.05
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
        Market Cap (million EUR)                                           96        GlobalData

        Enterprise Value (million EUR)                                     85
        Shares Outstanding (million)                                       15
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance                                                         Recent Developments
                                                                                      May 14, 2013         Gentium Reports Revenue Of €8.1m In Q1
                                                                                                           2013
                                                                                      Mar 28, 2013         Gentium Reports Revenue Of €29m In 2012
                                                                                      Nov 15, 2012         Gentium Reports Revenue Of €5.3m In Q3
                                                                                                           2012
                                                                                      Sep 13, 2012         Gentium Reports Revenue Of €8.5m In Q2
                                                                                                           2012
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData

       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData




Gentium S.p.A. (GENT) - Financial and Strategic SWOT Analysis                                                                  Reference Code: GDPH56864FSA
Review
Source : www.globalcompanyintelligence.com                                                                                                                     Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 4
          List of Figures ................................................................................................................................................................................. 4
       Section 1 - About the Company.......................................................................................................................................................... 5
       Gentium S.p.A. - Key Facts ................................................................................................................................................................ 5
       Gentium S.p.A. - Key Employees ....................................................................................................................................................... 6
       Gentium S.p.A. - Key Employee Biographies ..................................................................................................................................... 7
       Gentium S.p.A. - Major Products and Services .................................................................................................................................. 8
       Gentium S.p.A. - Pharmaceutical Pipeline Products Data .................................................................................................................. 9
          Gentium S.p.A., Pipeline Products by Therapy Area ...................................................................................................................... 9
          Gentium S.p.A., Pipeline Products by Development Phase .......................................................................................................... 10
       Gentium S.p.A. - History ................................................................................................................................................................... 12
       Gentium S.p.A. - Company Statement ............................................................................................................................................. 14
       Gentium S.p.A. - Locations And Subsidiaries ................................................................................................................................... 16
          Head Office ................................................................................................................................................................................... 16
          Other Locations & Subsidiaries ..................................................................................................................................................... 16
       Section 2 – Company Analysis ......................................................................................................................................................... 17
       Gentium S.p.A. - Business Description............................................................................................................................................. 17
       Gentium S.p.A. - Corporate Strategy ................................................................................................................................................ 18
       Gentium S.p.A. - SWOT Analysis ..................................................................................................................................................... 19
          SWOT Analysis - Overview........................................................................................................................................................... 19
          Gentium S.p.A. - Strengths ........................................................................................................................................................... 19
             Strength - Sturdy Research and Development Activities ........................................................................................................... 19
             Strength - Intellectual Property .................................................................................................................................................. 19
             Strength - Strong Liquidity Position ........................................................................................................................................... 19
          Gentium S.p.A. - Weaknesses ...................................................................................................................................................... 19
             Weakness - Business Concentration: the UK............................................................................................................................ 19
             Weakness - Reliance on the Third Parties ................................................................................................................................ 20
          Gentium S.p.A. - Opportunities ..................................................................................................................................................... 20
             Opportunity - Orphan Drug Designation .................................................................................................................................... 20
             Opportunity - Licensing and Distribution Agreements ............................................................................................................... 20
             Opportunity - Market Potential: Oncology.................................................................................................................................. 20
          Gentium S.p.A. - Threats .............................................................................................................................................................. 20
             Threat - Competitive Pressures ................................................................................................................................................. 20
             Threat - Government Regulations ............................................................................................................................................. 21
             Threat - Growing Parallel Trade in Europe ................................................................................................................................ 21
       Gentium S.p.A. - Key Competitors ................................................................................................................................................... 22
       Section 3 – Company Financial Ratios ............................................................................................................................................. 23
       Financial Ratios - Capital Market Ratios........................................................................................................................................... 23
       Financial Ratios - Annual Ratios ...................................................................................................................................................... 23
       Performance Chart ........................................................................................................................................................................... 25
       Financial Performance...................................................................................................................................................................... 25
       Financial Ratios - Interim Ratios....................................................................................................................................................... 26
       Financial Ratios - Ratio Charts ......................................................................................................................................................... 27
       Section 4 – Company’s Lifesciences Financial Deals and Alliances ................................................................................................ 28


Gentium S.p.A. (GENT) - Financial and Strategic SWOT Analysis                                                                                                  Reference Code: GDPH56864FSA
Review
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
          Gentium S.p.A., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 .................................................................... 28
          Gentium S.p.A., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 ................................................................... 29
       Gentium S.p.A., Recent Deals Summary ......................................................................................................................................... 30
       Section 5 – Company’s Recent Developments ................................................................................................................................ 31
          Gentium S.p.A., Recent Developments .................................................................................................
				
DOCUMENT INFO
Description: Gentium S.p.A. (GENT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history. Highlights Gentium S.p.A. (Gentium) is a biopharmaceutical company. It researches, develops and manufactures pot
BUY THIS DOCUMENT NOW PRICE: $125 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.